Glycine max (Edamame)

Edamame (Glycine max) is an immature soybean rich in isoflavones such as genistein and daidzein, along with complete protein, dietary fiber, and polyunsaturated fatty acids. These bioactive compounds interact with estrogen receptors and antioxidant pathways, contributing to their studied cardiometabolic and hormonal modulating effects.

Origin & History

Glycine max (Edamame) refers to immature green soybeans harvested at the R6 developmental stage when beans fill 80-90% of the pod cavity. Originating from East Asia, edamame is consumed as a whole food and is typically powdered after drying and sieved for chemical analysis rather than extracted.

Historical & Cultural Context

No information on historical or traditional medicinal uses of edamame in any medical systems was found in the available research. The sources focus exclusively on modern analytical chemistry and agricultural aspects.

Health Benefits

• Rich in proteins, oils, fibers, sugars, and free alanine with content varying by genotype and location (no clinical evidence available)
• Contains neutral detergent fiber (NDF) and starch (no clinical evidence available)
• May possess in vitro antioxidant potential via ethanolic extracts (preliminary evidence only)
• Source of free sugars including sucrose, fructose, glucose, raffinose, and stachyose (no clinical evidence available)
• No clinical trials or human studies available to support specific health benefits

How It Works

Genistein and daidzein, the primary isoflavones in Glycine max, act as phytoestrogens by binding to estrogen receptor beta (ERβ) with higher affinity than ERα, modulating gene transcription involved in cell proliferation and inflammation. Genistein also inhibits tyrosine kinase activity and topoisomerase II, influencing cell signaling cascades related to oxidative stress. Ethanolic extracts of edamame demonstrate in vitro free radical scavenging activity, potentially via phenolic compounds that donate hydrogen atoms to neutralize reactive oxygen species.

Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses on edamame for biomedical applications were found in the available research. The existing studies focus solely on chemical composition, growth characteristics, or in vitro antioxidant potential without any clinical data or PubMed PMIDs available.

Clinical Summary

Most available evidence on Glycine max edamame specifically is preliminary, relying on in vitro antioxidant assays and compositional analyses rather than robust clinical trials in humans. Broader soy isoflavone research — largely from randomized controlled trials involving 50–200 participants — suggests modest reductions in LDL cholesterol (approximately 3–5%) and improvements in bone mineral density in postmenopausal women, though edamame-specific dosing data remain limited. Neutral detergent fiber and starch content in edamame have been characterized by genotype and growing location, but their isolated clinical effects have not been independently studied. The overall evidence base for edamame as a distinct therapeutic ingredient is weak; most benefits are extrapolated from broader soy research.

Nutritional Profile

Edamame (immature Glycine max) provides approximately 11-13g protein per 100g fresh weight (complete protein containing all essential amino acids, with lysine ~0.6g/100g and leucine ~0.8g/100g); total fat ~5-6g/100g including polyunsaturated fatty acids (linoleic acid ~50-55% of fatty acid profile, alpha-linolenic acid ~8-10%); total carbohydrates ~8-10g/100g with dietary fiber ~4-5g/100g (neutral detergent fiber fraction present); free sugars include sucrose (~1.5-2.5g/100g), glucose, fructose, raffinose, and stachyose (the latter two are oligosaccharides associated with flatulence due to limited human alpha-galactosidase activity). Starch content is moderate (~1-3g/100g) varying significantly by genotype and harvest location. Micronutrients: folate (~111mcg/100g, ~28% DV), vitamin K1 (~26mcg/100g), vitamin C (~6mg/100g), manganese (~1mg/100g, ~43% DV), phosphorus (~169mg/100g), magnesium (~64mg/100g), iron (~2.3mg/100g, non-heme, bioavailability ~5-10% due to phytate content), potassium (~436mg/100g), and calcium (~63mg/100g). Bioactive compounds: isoflavones (genistein ~18-24mg/100g fresh weight, daidzein ~7-10mg/100g) with bioavailability influenced by gut microbiome composition; phytic acid (~1-2g/100g dry weight) reduces mineral bioavailability; ethanolic extracts demonstrate in vitro antioxidant activity attributed to phenolic compounds and isoflavones. Protein digestibility is estimated at 75-85% in whole cooked form; cooking increases isoflavone bioavailability relative to raw consumption.

Preparation & Dosage

No clinically studied dosage ranges are available for any form of edamame (extract, powder, or standardized) as no human trials have been documented. Analytical methods describe laboratory preparation using 0.15g dry powder for extraction analysis only, not therapeutic dosing. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients identified due to lack of clinical research

Safety & Interactions

Edamame is generally recognized as safe for most adults when consumed as food, but individuals with soy allergies may experience reactions ranging from mild urticaria to anaphylaxis. Due to its phytoestrogenic isoflavone content, edamame may interact with tamoxifen and other hormone-sensitive therapies, potentially altering their efficacy, and its safety in hormone-receptor-positive breast cancer patients remains debated. High intake may affect thyroid hormone synthesis by inhibiting thyroid peroxidase, particularly in individuals with iodine deficiency. Pregnant women are generally advised to consume edamame only in typical dietary amounts, as high-dose isoflavone supplementation has not been established as safe during pregnancy.